Jaren Jackson Jr. will miss the remainder of the 2025-26 NBA season after being diagnosed with PVNS growth in his left knee, an injury that will require surgery to protect his long-term health, according to league sources cited by Chris Haynes.
The injury was identified after his trade from the Memphis Grizzlies to the Utah Jazz before the close of the NBA trade deadline. The power forward was only able to play three games with the Salt Lake City franchise, averaging 22.3 points, 4.3 rebounds, and 2.7 assists in 24.1 minutes per night, making an immediate impact during his short time with the team.
Before the start of this season, the Grizzlies had shown strong commitment to Jackson, extending his contract for five years and $240 million, establishing him as a cornerstone of the project in Memphis. However, his move to Utah and now this surgical procedure significantly alter the sports landscape for both the player and his new team.
Injury aiding Jazz's tanking strategy
Jackson's absence also has implications for the Jazz's front office. Currently, Utah sits with the sixth worst record in the league, a precarious position considering that their first-round draft pick is protected in the top 8 and belongs to the Oklahoma City Thunder. The team's performance without their recent addition could directly impact whether that pick will be conveyed or not.
So far, the franchise has not released an official schedule for the surgery or provided an estimated recovery timeline. The priority, according to available information, is to ensure Jackson's full recovery and safeguard his long-term career.
This news is an automatic translation. You can read the original news, Más fácil el tanking para Utah Jazz: Jaren Jackson Jr., fuera el resto de la temporada